Hematopoietic stem cell transplant (SCT) remains a curative option for a variety of malignant and non-malignant disorders in children. Following transplant a proportion of SCT recipients become critically ill and need intensive care. Critical illness may occur in the setting of transplant complications such as graft versus host disease (GVHD), idiopathic pneumonia syndrome (IPS), veno-occlusive disease (VOD) and transplant associated thrombotic microangiopathy (TA-TMA). Hence, familiarity with recent advances in the transplant process and complications is crucial for the intensivist. This article will highlight common complications encountered in the critically ill SCT recipient.
Key points
- •
Despite advances in transplant techniques, recipients of stem cell transplant (SCT) remain a complex cohort of patient, with disproportionately high morbidity and mortality.
- •
Outcomes for these patients seem to be improving.
- •
Given the ever-expanding indications and complexity of SCT, it is important for SCT physicians and intensivists to work closely together to ensure the best possible outcomes for critically ill recipients of SCT.